![]() ![]() Most reactions were reported from within hours to one month after administration. Most reactions were mild to moderate, but some led to discontinuation or required corticosteroid treatment. Hypersensitivity Reactions: Hypersensitivity reactions, including rash, pruritus, drug hypersensitivity, and urticaria were reported with AJOVY in clinical trials. Reactions have included anaphylaxis and angioedema. Monthly dosing option 225 mg subcutaneous or Quarterly dosing option 675 mg (225 mg x 3) subcutaneous.Ĭontraindications: AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients.See full Terms and Conditions for eligibility and restrictions. Please note, this offer is not available for patients eligible for Medicare, Medicaid, or any other public payer coverage. Out-of-pocket costs may vary based on insurance coverage.Learn more about getting your patients startedĮligible commercially insured patients can use the Savings Offer for AJOVY, which may cost as little as $5 for each Monthly prescription OR each Quarterly prescription.* † They can start by registering with the Patient Services Portal. You or your office staff should work with your patients to determine plan coverage.įor additional support, Shared Solutions® is available to help your patients with financial assistance. ![]() ![]() Each insurer determines its own policies, and coverage for AJOVY continues to improve. We are committed to helping your patients fill their prescription for AJOVY. FAQ > Covered by insurance Covered by insurance ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |